EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis. - sprookjes - yvandenbroek - TriplyDB

EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.

EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.

http://www.wikidata.org/entity/Q47764778

about

Efficacy and Safety of Subcutaneous Allergen Immunotherapy for Allergic Rhinitis.Dose-finding study of carbamylated monomeric allergoid tablets in grass-allergic rhinoconjunctivitis patients.EAACI guidelines on allergen immunotherapy: Prevention of allergy.Oral myeloid cells uptake allergoids coupled to mannan driving Th1/Treg responses upon sublingual delivery in mice.Adherence and quality of life in adults and children during 3-years of SLIT treatment with Grazax-a real life study.The future outlook on allergen immunotherapy in children: 2018 and beyond.SCIT with a high-dose house dust mite allergoid is well tolerated: safety data from pooled clinical trials and more than 10 years of daily practice analyzed in different subgroups Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT A Sensitive and Rapid UPLC-MS/MS Method for Determination of Monosaccharides and Anti-Allergic Effect of the Polysaccharides Extracted from Sublingual allergen immunotherapy for respiratory allergy: a systematic review Immunotherapy and Asthma in Children Duration of Allergen Immunotherapy for Long-Term Efficacy in Allergic Rhinoconjunctivitis

P2860

Q47118742-64E5C6C1-9391-404A-AA87-516EA1C1719B Q47713994-F24C3E05-6614-43F0-B0BD-609954C1D5A4 Q47774546-FBDF5D76-E241-495F-9B56-4B5D1EA50247 Q48271280-D38F1380-E7E6-4FD2-9596-7518BBA9DD87 Q49508636-7CEC20E8-3FAD-45F3-97D7-3333692A6FEB Q55662210-9ACD3226-3081-4BC6-B990-2F7C13AB5FF6 Q57193203-33DAD583-06A1-4709-B0BC-60040377B5C0 Q58580218-B742FC39-AA05-48F1-A20C-2A67EFCD8F44 Q58697461-DC3E464B-140B-4B22-A632-4646E02BF8CC Q58700135-24CD3F18-7284-4535-90D6-ABD14F96258C Q58729387-15B3AF7E-17B2-4237-A6C6-200FF6E0CD02 Q58780229-1358A9A4-0FD1-4FBF-9AC8-A7A8944E177B

P2860

EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.

http://www.wikidata.org/entity/Q47764778

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.

@en

EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.

@nl

type

label

EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.

@en

EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.

@nl

prefLabel

EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.

@en

EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.

@nl

P1433

Q47764778-4B56C434-0621-460C-8B38-29DB95EF00B4

P1476

Q47764778-D31924D0-4756-49E6-9159-2AF56D609AFC

P2093

Q47764778-00AF4C19-8461-465A-8248-AFBE441BE317

Q47764778-0EAA8B41-733D-41B4-9264-1324C2B68B5E

Q47764778-10DDA9C7-4290-4704-86A1-1659FC058125

Q47764778-14CBE3E4-E115-4BF9-BF0B-7ABD53444049

Q47764778-24E8FCFC-7D8C-47F4-A925-ED1E5D8BF707

Q47764778-29856E55-25BE-45AD-BF95-9D537900CF53

Q47764778-2B7B33F7-2B9A-456C-8246-1A47BA14648B

Q47764778-3453EAC1-15AE-41BC-AA72-B1C5E53D38A6

Q47764778-3E3A35BA-9229-419C-B26C-181BEA9961DD

Q47764778-4062F027-E68F-447E-B6ED-D39573257AAD

P2860

Q47764778-01AD7924-86F8-4D53-862A-707F420E6978

Q47764778-03BA0317-3BFF-41FF-95A0-C33054096076

Q47764778-05116B3F-9D29-4EB1-A4E6-859F1876A299

Q47764778-064E67C6-3BDA-45A6-B47B-B4A915F30613

Q47764778-096BB7EC-FF4C-415E-9821-DC26CC2DFBFC

Q47764778-0B5F5189-0A79-49BC-A494-350F709CDA4B

Q47764778-0EF85ED7-B776-4924-A698-DB2727201C8E

Q47764778-0F64FCC3-B38A-4449-9FE1-35AC8E3982CE

Q47764778-0FDE6169-1B54-4FED-BC8A-31F1133CCE7E

Q47764778-112F7D96-F2B0-4D1E-838B-541B014BA10D

P304

Q47764778-59676032-433A-491F-A7E3-E7F2595A0E74

P31

Q47764778-4F71769B-83E0-4B23-B419-071CA441C768

P356

Q47764778-D26E869F-31A6-4EBE-BDE5-2F1B7472B238

P433

Q47764778-1D76EDB3-C795-4D51-83A8-7DD1A33E3F1B

P478

Q47764778-9481F62A-A566-4A86-A1BB-CA689FF2236B

P50

Q47764778-15692C1B-C30D-458B-9344-7082F594A46E

Q47764778-26011BAD-C20B-48F7-AF43-AFADFF997005

Q47764778-26FC5645-F2AF-42F4-8D24-8E02F227C496

Q47764778-665EAF43-19A8-42C9-BDED-83E25E7E1C80

Q47764778-81DC9BC6-D3E0-4701-9291-482110510769

Q47764778-A1DD815A-A42C-4A0C-B472-102837E6B539

Q47764778-B3995110-9F4B-4870-BF8E-7D67473D61DC

Q47764778-B7736D80-430A-4813-8654-947D83402A85

Q47764778-EDCD3794-B97B-4348-925E-83FE252B7159

P577

Q47764778-C3F69C9B-89D5-4AFD-A4B4-9A6A0DF9DD2F

P698

Q47764778-22D60A13-F93C-4C54-A63A-BB9B334BCE59

P921

Q47764778-48B58670-6B1B-462B-934F-9FC8032FCF17

Q47764778-CCD9CCA7-541D-48A2-B9D1-AB64C6FDEE94

P356

P1433

P1476

EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis

@en

P2093

A Muraro

http://www.w3.org/2001/XMLSchema#string

A Sheikh

http://www.w3.org/2001/XMLSchema#string

A Williams

http://www.w3.org/2001/XMLSchema#string

C A Akdis

http://www.w3.org/2001/XMLSchema#string

C Cingi

http://www.w3.org/2001/XMLSchema#string

D Ryan

http://www.w3.org/2001/XMLSchema#string

E A Pastorello

http://www.w3.org/2001/XMLSchema#string

E Angier

http://www.w3.org/2001/XMLSchema#string

E Hamelmann

http://www.w3.org/2001/XMLSchema#string

E-M Varga

http://www.w3.org/2001/XMLSchema#string

P2860

Sublingual immunotherapy for asthma

House dust mite avoidance measures for perennial allergic rhinitis

Management of the polyallergic patient with allergy immunotherapy: a practice-based approach

Allergen immunotherapy in pregnancy

Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project

Sublingual immunotherapy: World Allergy Organization position paper 2013 update.

Types of sensitization to aeroallergens: definitions, prevalences and impact on the diagnosis and treatment of allergic respiratory disease

Intradermal grass pollen immunotherapy increases TH2 and IgE responses and worsens respiratory allergic symptoms.

Long-term clinical efficacy of grass-pollen immunotherapy.

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study.

P304

765-798

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ALL.13317

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P50

Peter W Hellings

Olympia Tsilochristou

Edward Frank Knol

Carsten B Schmidt-Weber

Désirée E. Larenas-Linnemann

P577

2017-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28940458

http://www.w3.org/2001/XMLSchema#string

P921

rhinoconjunctivitis